Clinical Division Genetic Testing and Next Generation Sequencing Services for Active Clinical Protocols- bone marrow failure syndromes, aplastic anemia, myeloid neoplasms, clonal hematopoiesis, and related hematologic disorders

Estimated Value: $300,000
Closing Soon 5 days left MarylandHealthcaresolicitation
Sep 1, 2026
Sep 8, 2026 4:00 PM
Healthcare
solicitation
622110
AI Summary
This bid is for the provision of genetic testing and next-generation sequencing services to support active clinical protocols related to various hematologic disorders, including bone marrow failure syndromes and myeloid neoplasms.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Genetic Testing and Next Generation Sequencing Services for Bone Marrow Failure Syndromes 1 lot $75,000.00 $75,000.00 Medical
Genetic Testing and Next Generation Sequencing Services for Aplastic Anemia 1 lot $50,000.00 $50,000.00 Medical
Genetic Testing and Next Generation Sequencing Services for Myeloid Neoplasms 1 lot $100,000.00 $100,000.00 Medical
Genetic Testing and Next Generation Sequencing Services for Clonal Hematopoiesis 1 lot $50,000.00 $50,000.00 Medical
Genetic Testing and Next Generation Sequencing Services for Related Hematologic Disorders (general category) 1 lot $25,000.00 $25,000.00 Medical
Estimated Bid Value$300,000.00

Want the full details?

Sign up free to see the agency name, 2 documents, contact info, and the original bid posting link.

📎 UChicago_Testing_Statement_of_Work_SOW.pdf View
📎 Notice_of_Intent_75N98026Q01002.pdf View
Sign Up Free →

Related Bids

Browse More Bids

Bids in MarylandHealthcare BidsSOLICITATION BidsClosing Soon All Bids